EP Patent

EP1162974A1 — Quinazoline formulations and therapeutic use thereof

Assigned to Parker Hughes Institute · Expires 2001-12-19 · 24y expired

What this patent protects

Pharmaceutical compositions for parenteral administration of poorly soluble quinazoline compounds in the form of microemulsions or micellar solutions are described. The compositions are useful in treating patients suffering from cancer or having allergic reactions.

USPTO Abstract

Pharmaceutical compositions for parenteral administration of poorly soluble quinazoline compounds in the form of microemulsions or micellar solutions are described. The compositions are useful in treating patients suffering from cancer or having allergic reactions.

Drugs covered by this patent

Patent Metadata

Patent number
EP1162974A1
Jurisdiction
EP
Classification
—
Expires
2001-12-19
Drug substance claim
No
Drug product claim
No
Assignee
Parker Hughes Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.